MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition

Dai Horiuchi, Leonard Kusdra, Noelle E. Huskey, Sanjay Chandriani, Marc E. Lenburg, Ana Maria Gonzalez-Angulo, Katelyn J. Creasman, Alexey V. Bazarov, James W. Smyth, Sarah E. Davis, Paul Yaswen, Gordon B. Mills, Laura J. Esserman, Andrei Goga

Research output: Contribution to journalArticlepeer-review

234 Scopus citations

Fingerprint

Dive into the research topics of 'MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences